| 摘要 |
The present invention relates to a pharmaceutical composition for treating renal diseases, containing dipyridamole as an active ingredient. More specifically, the present invention relates to a pharmaceutical use, for treating renal diseases, of dipyridamole, by inhibiting the proliferation of mesangial cells and decreasing the excretion of urinary albumin, wherein the dipyridamole is currently used as a treatment use for the support of anticoagulant agents so as to prevent angina and thromboembolism and for the prevention of a stroke. |
